08 August 2021

safety alerts

Reference: CIR-2021-00000130

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the Circular issued by the MOHAP for perusal and adhere to what is stated

 

 Lifting the Suspension on the Registration & Marketing of the Product Amopress (Amlodipine) 5mg Capsules

 

Thanks in advance for your good co-operation

Drug Control Sect

Health Regulation Sector

DHA

Supporting Documents:

Amopress (Amlodipine) 5mg Capsules رفع تعليق-1.pdf:

View Document